Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
'''Approved Call Summaries:''' | '''Approved Call Summaries:''' | ||
| + | *[[Media:02 12 2021 QIBA CEUS BC Call Summary-FINAL-MA.pdf|February 12, 2021]] | ||
*[[Media:11 13 2020 QIBA CEUS BC Call Summary-FINAL-MA.pdf|November 13, 2020]] | *[[Media:11 13 2020 QIBA CEUS BC Call Summary-FINAL-MA.pdf|November 13, 2020]] | ||
*[[Media:10 09 2020 QIBA CEUS BC Call Summary-FINAL-MA.pdf|October 9, 2020]] | *[[Media:10 09 2020 QIBA CEUS BC Call Summary-FINAL-MA.pdf|October 9, 2020]] | ||
Revision as of 22:01, 25 February 2021
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
- February 12, 2021
- November 13, 2020
- October 9, 2020
- August 14, 2020
- July 10, 2020
- June 12, 2020
- May 8, 2020
- March 13, 2020
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: